The charts, technical indicators, and signals here are generated live from Tech Trader, a fully autonomous trading system with no human intervention.
The second chart (if available) is a combination of Tech Trader with the Grok AI (from xAI) interpreting the chart and making trading decisions, including elaborate reports at the bottom explaining any given day.
Follow trades and activity on The Tech Trader Wall and Tech Trader + Grok Wall.
Tech Trader Only
(Technical Analysis + Trades by Tech Trader)
Grok's Analysis
| 2026-04-10 | CASH |
| 2026-04-09 | CASH |
|
Summary: ...
|
|
| 2026-04-08 | CASH |
|
Summary: ...
|
|
| 2026-04-07 | CASH |
|
Summary: Staying CASH on ISRG at ~451 close on 4/7/26 as daily chart shows persistent downtrend from Jan 593 high with lower highs/lows, failure to hold 460, and our last 6 trades all losers including the recent buy 464.45/sell 452.58. ...
|
|
| 2026-04-06 | SOLD |
|
Summary: Closing our long from 4/1/26 at $464.45 and moving to cash as ISRG dropped to $451.78 on 4/6, failing to hold the bounce with no reversal signals in the ongoing decline from the Jan $593 high. ...
|
|
| 2026-04-02 | HOLD LONG |
|
Summary: ...
|
|
| 2026-04-01 | BUY |
|
Summary: ...
|
|
| 2026-03-31 | COVERED |
|
Summary: ...
|
|
| 2026-03-30 | HOLD SHORT |
|
Summary: We're holding the short as ISRG closed near the lows again at 451.53 after failing to sustain early gains above 459, showing sellers remain in control near the breakdown level....
|
|
| 2026-03-27 | SHORT |
|
Summary: After staying in cash due to ongoing choppy weakness without a clear setup, we're going short now as the stock broke down sharply to 451 on increased volume, confirming the downside trend....
|
|
| 2026-03-26 | CASH |
|
Summary: ISRG is showing continued weakness with another lower low at 465 before closing at 470.3 on low volume, so we remain in cash....
|
|
| 2026-03-25 | CASH |
|
Summary: ...
|
|
| 2026-03-24 | SOLD |
|
Summary: ...
|
|
| 2026-03-23 | BUY |
|
Summary: After staying in cash due to the stapler recall and choppy range, we're going long now as that issue appears contained per analysts, the stock bounced strongly off the 474 lows to hit 489 today, and long-term sentiment is bullish....
|
|
| 2026-03-20 | CASH |
|
Summary: We're remaining in cash as ISRG closed lower near 474 today amid the ongoing stapler recall news, with no breakout from the recent choppy range....
|
|
| 2026-03-19 | CASH |
|
Summary: ...
|
|
| 2026-03-18 | CASH |
|
Summary: We're staying in cash as ISRG closed lower at 479.25 after retesting the 472 area, continuing the choppy and indecisive price action in the 470-495 zone....
|
|
| 2026-03-17 | CASH |
|
Summary: We're staying in cash as ISRG closed essentially flat at 483.92 after probing toward 494 but reversing on very low volume, showing the same indecision we saw yesterday....
|
|
| 2026-03-16 | CASH |
|
Summary: Recent price action shows ISRG still in a choppy downtrend from February highs around 506, with our last few long entries quickly turning into losses amid high volatility. ...
|
|
| 2026-03-13 | SOLD |
|
Summary: Exit long on ISRG after sharp drop below lower Bollinger Band to $471.63 amid bearish MACD divergence and lack of volume support, signaling weakening momentum in ongoing choppy range below $500 despite prior Citi upgrade....
|
|
| 2026-03-12 | BUY |
|
Summary: Re-entering long on ISRG one day after exit as Citi's upgrade to Buy on recent selloff, oversold RSI 38 touching lower Bollinger Band, and upbeat 2026 earnings forecasts provide strong bullish catalysts at a lower price, overriding previous choppy consolidation below $500....
|
|
| 2026-03-11 | SOLD |
|
Summary: ISRG's choppy sideways action below $500 resistance with declining MACD and neutral RSI signals weakening momentum, prompting exit from long position after 11 bars to avoid whipsaw in range-bound consolidation....
|
|
| 2026-03-10 | HOLD LONG |
|
Summary: ISRG tests $485 support on light volume with neutral RSI 41/MACD buy signal, Strong Buy consensus PT $610+ amid Europe expansion and da Vinci catalysts.[[1]](https://finance.yahoo.com/quote/ISRG)[[2]](https://www.tradingview.com/symbols/NASDAQ-ISRG/technicals/)...
|
|
| 2026-03-09 | HOLD LONG |
|
Summary: ISRG dips to $485.42 on low volume but defends $480 support with neutral RSI 47 and Strong Buy consensus PT $610+, fundamentals like Europe expansion intact.[[1]](https://finance.yahoo.com/quote/ISRG/history)[[2]](https://www.investing.com/equities/intuitive-surgical-inc-technical)[[3]](https://finance.yahoo.com/quote/ISRG)...
|
|
| 2026-03-06 | HOLD LONG |
|
Summary: ISRG dips -2% to $486 but defends $478 support amid neutral RSI 50 and Strong Buy consensus PT $610+, da Vinci Europe expansion intact.[[1]](https://www.investing.com/equities/intuitive-surgical-inc-technical)[[2]](https://www.marketwatch.com/investing/stock/isrg/analystestimates?gaa_at=eafs&gaa_n=AWEtsqctZAOOgJZE1FcwanNKtBOUosaG3iQQ1o4MdejQotd231o8ABmB84uF&gaa_sig=qUX1GNXfRypOJ__yFY_rm-1AeNuMS7VeY0lIGC6fu3dHACrUJyzPuPTKL24asDMYJ14GCLPu7Ecq_GO_nD7W7g%3D%3D&gaa_ts=69ab46b8)...
|
|
| 2026-03-05 | HOLD LONG |
|
Summary: ISRG consolidates ~$500 above key support with Strong Buy consensus (PT $618 avg), da Vinci growth intact post-Q4 beat.[[1]](https://www.perplexity.ai/finance/ISRG/analysis)[[2]](https://www.tradingview.com/symbols/NASDAQ-ISRG/forecast)...
|
|
| 2026-03-04 | HOLD LONG |
|
Summary: Holding long on ISRG as price rebounds above $500 with improving MACD, high STO signaling momentum, positive Q4 earnings beat and 13-15% 2026 growth guidance outweighing short-term volatility....
|
|
| 2026-03-03 | HOLD LONG |
|
Summary: Holding long on ISRG amid bullish European expansion news, institutional buying, positive analyst targets, and improving MACD crossover with price holding key support....
|
|
| 2026-03-02 | HOLD LONG |
|
Summary: Holding long on ISRG as price bounces off key support at $490 amid bullish European expansion news, improving MACD crossover, neutral RSI, and overbought STO signaling sustained momentum despite minor pullback and mixed sentiment....
|
|
| 2026-02-27 | HOLD LONG |
|
Summary: Holding long on ISRG as price holds above entry amid improving MACD histogram, neutral RSI, overbought STO signaling momentum, with bullish news like Da Vinci 5 clearance and 18.9% Q4 growth projecting 21% upside despite minor pullback....
|
|
| 2026-02-26 | HOLD LONG |
|
Summary: Holding long on ISRG amid continued bullish momentum from Da Vinci 5 cardiac clearance, strong Q4 growth with 21% revenue rise, and analyst projections of 21% upside, as price rebounds to 506 with improving MACD and neutral RSI signaling sustained rebound potential....
|
|
| 2026-02-25 | HOLD LONG |
|
Summary: Holding long on ISRG as Da Vinci 5 cardiac clearance and analyst upgrades fuel bullish momentum, with MACD crossover and RSI bounce signaling rebound potential amid healthcare sector strength....
|
|
| 2026-02-24 | BUY |
|
Summary: Re-entering long on ISRG as bullish MACD crossover, RSI bounce from oversold, positive news like Da Vinci 5 cardiac clearance and analyst upgrades override prior insider selling and resistance concerns, with price rebound justifying quick re-entry after yesterday's exit....
|
|
| 2026-02-23 | SOLD |
|
Summary: ISRG drops to $492.38 amid insider selling and bearish MACD, failing to sustain above $500 resistance despite positive analyst views on Da Vinci growth, prompting exit from long position entered at $485.84 after 5 days to avoid further downside in choppy range....
|
|
| 2026-02-20 | HOLD LONG |
|
Summary: ISRG rebounds to $503.82 holding above $495 support with bullish MACD crossover, rising STO, and positive Da Vinci system adoption news amid healthcare sector strength....
|
|
| 2026-02-19 | HOLD LONG |
|
Summary: ISRG dips -0.25% to $499.53 but holds $495 support with Zacks #1 Strong Buy, avg PT $612, and fresh international procedure growth news....
|
|
| 2026-02-18 | HOLD LONG |
|
Summary: Holding long on ISRG as price surges to $501.14 with bullish MACD crossover, rising STO momentum, and catalysts like Da Vinci 5 cardiac clearance driving upside potential despite valuation concerns....
|
|
| 2026-02-17 | HOLD LONG |
|
Summary: Holding long on ISRG as price rebounds above entry with bullish MACD crossover and STO momentum amid FDA clearance momentum, despite broader downtrend, eyeing potential upside to $500+ resistance....
|
|
| 2026-02-13 | BUY |
|
Summary: Re-entering long on ISRG one day after exit as fresh FDA clearance for Da Vinci 5 cardiac procedures and upbeat R&D investments counter previous insider selling and procedure slowdown worries, with price bouncing from oversold RSI 35 amid healthcare sector strength signaling high-upside rebound potential....
|
|
| 2026-02-12 | SOLD |
|
Summary: Exit long on ISRG as price fell below entry amid bearish news like insider selling and slowing da Vinci procedures, with oversold RSI failing to hold support in ongoing downtrend....
|
|
| 2026-02-11 | HOLD LONG |
|
Summary: Holding long on ISRG as price shows recovery from recent lows with improving RSI and positive analyst expectations outweighing minor tariff concerns....
|
|
| 2026-02-10 | HOLD LONG |
|
Summary: Holding long on ISRG as the price recovery from oversold levels continues with bullish momentum in technicals and positive catalysts like Da Vinci 5 progress, outweighing short-term volatility....
|
|
| 2026-02-09 | HOLD LONG |
|
Summary: Holding long on ISRG as the slight price uptick from oversold levels aligns with bullish catalysts like Da Vinci 5 advancements and positive earnings history, despite recent volatility, with no immediate bearish shifts warranting an early exit....
|
|
| 2026-02-06 | BUY |
|
Summary: Entering long on ISRG at oversold RSI 29 with bullish catalysts like Da Vinci 5 cardiac clearance and global expansion plans justifying re-entry after recent exit, as lower price and new positive developments override prior consolidation concerns....
|
|
| 2026-02-05 | CASH |
|
Summary: ISRG drifts lower to ~$525 on fading volume below 50DMA, bearish technicals persist—no reversal signals yet.[[1]](https://finance.yahoo.com/quote/ISRG)[[2]](https://www.tradingview.com/symbols/NASDAQ-ISRG/technicals)...
|
|
| 2026-01-27 | CASH |
|
Summary: ISRG edges up 0.1% to $529.54 but lingers below 50DMA $531 amid low volume, bearish MAs and post-earnings fade—no clear reversal.[[1]](https://www.cnbc.com/quotes/ISRG)[[2]](https://www.investing.com/equities/intuitive-surgical-inc-technical)...
|
|
| 2026-01-26 | CASH |
|
Summary: ISRG dips to $524 on low volume post-earnings fade, testing support amid bearish patterns like double top—no reversal yet.[[1]](https://stockinvest.us/stock/ISRG)[[2]](https://x.com/i/status/2015518921634283814)...
|
|
| 2026-01-23 | CASH |
|
Summary: Sideways grind persists without volume confirmation, staying sidelined preserves edge amid fading momentum....
|
|
| 2026-01-22 | SOLD |
|
Summary: Prolonged $570-573 consolidation without volume breakout erodes momentum; exit to lock gains and reset for clearer signal....
|
|
| 2026-01-21 | HOLD LONG |
|
Summary: ISRG anchors ~$573 over $570 support in tight range, RSI basing bullishly with da Vinci catalysts coiled tight....
|
|
| 2026-01-20 | HOLD LONG |
|
Summary: ISRG steady ~$573 above $570 support in ongoing consolidation, RSI basing with robotics catalysts primed....
|
|
| 2026-01-16 | HOLD LONG |
|
Summary: ISRG clings to $573 amid low volume lull, $570 support ironclad with RSI poised for robotics breakout....
|
|
| 2026-01-15 | HOLD LONG |
|
Summary: ISRG steady ~$573 above $570 base, RSI basing bullishly in elite robotics consolidation....
|
|
| 2026-01-14 | HOLD LONG |
|
Summary: ISRG flat ~$573 hugging $570 support, RSI coiling bullishly in robotics leader consolidation....
|
|
| 2026-01-13 | HOLD LONG |
|
Summary: ISRG idles ~$573 above $570 base, RSI neutral-bullish amid robotics rotation setup....
|
|
| 2026-01-12 | HOLD LONG |
|
Summary: ISRG steady ~$573 on quiet volume, $570 support locked with RSI coiling for da Vinci-driven thrust....
|
|
| 2026-01-09 | HOLD LONG |
|
Summary: ISRG hugs $573 amid low volume, $570 floor solid with RSI basing amid da Vinci momentum....
|
|
| 2026-01-08 | HOLD LONG |
|
Summary: ISRG flat ~$573 in quiet session, $570 base firm with RSI coiling for robotics-fueled breakout....
|
|
| 2026-01-07 | HOLD LONG |
|
Summary: ISRG edges +0.5% to $573 on balanced volume, $570 support solid with RSI strength signaling continuation....
|
|
| 2026-01-06 | HOLD LONG |
|
Summary: ISRG rebounds +0.8% to ~$572 on volume pickup, tariff dip digested with RSI curling up above $570 support....
|
|
| 2026-01-05 | HOLD LONG |
|
Summary: ISRG slips -1.2% to ~$570 on tariff fears and thin volume but holds $568 support, RSI basing for rebound....
|
|
| 2026-01-02 | HOLD LONG |
|
Summary: ISRG opens 2026 ~$577 flat above $575 entry on light volume, support holds with da Vinci catalysts reloading....
|
|
| 2025-12-31 | HOLD LONG |
|
Summary: ISRG edges +0.3% to ~$577 on light volume, defending $575 entry with golden cross and PT upgrades fueling bulls....
|
|
| 2025-12-30 | HOLD LONG |
|
Summary: ISRG holds post-entry poise ~$575 amid year-end flows, support firm with da Vinci catalysts reloading for 2026....
|
|
| 2025-12-29 | BUY |
|
Summary: ISRG lounges ~$566 in post-holiday hush, $566 fortress unbreakable with coiled RSI eyeing Jan fireworks....
|
|
| 2025-12-26 | SOLD |
|
Summary: ISRG has approached key resistance near 585 after a steady uptrend from the 574.23 entry, with positive momentum from recent highs and no immediate bearish catalysts, but profit-taking is warranted to lock in gains before potential reversal....
|
|
| 2025-12-24 | HOLD LONG |
|
Summary: ISRG remains in a confirmed uptrend with price above rising EMA and SMA, positive momentum from recent highs, and no bearish catalysts, supporting continued hold from the 574.23 entry targeting resistance near 585....
|
|
| 2025-12-23 | HOLD LONG |
|
Summary: ISRG maintains a strong uptrend with price above rising EMA and SMA, positive momentum indicators, and no immediate bearish catalysts or earnings risks, supporting continued hold from the 574.23 entry targeting resistance near 585....
|
|
| 2025-12-22 | HOLD LONG |
|
Summary: ISRG remains in a confirmed uptrend with EMA above SMA, both rising, price above both, recovering from mid-December support around 542-550 without bearish catalysts, supporting continued long hold near resistance but with momentum intact....
|
|
| 2025-12-19 | HOLD LONG |
|
Summary: ISRG maintains a solid uptrend with EMA above SMA, both rising, price above both and holding key support around 542-550, while recent price recovery from mid-December lows and no immediate bearish catalysts or earnings support continued long hold from 574.23....
|
|
| 2025-12-18 | HOLD LONG |
|
Summary: ISRG remains in a confirmed uptrend with EMA above SMA, both rising, price above both, holding above key support near 542-550 amid no immediate bearish catalysts or earnings, justifying continued long hold from 574.23 despite minor pullback....
|
|
| 2025-12-17 | HOLD LONG |
|
Summary: ISRG maintains an uptrend with EMA above SMA and both rising, price above key support at 542 amid positive robotic surgery demand and no bearish catalysts, justifying holding the long position despite pullback from 578 highs....
|
|
| 2025-12-16 | HOLD LONG |
|
Summary: ISRG remains in a confirmed uptrend with EMA above SMA and both rising, price holding above key support near 542 without breakdown, bolstered by strong robotic surgery demand and positive post-earnings momentum from October, justifying continued long hold despite recent pullback from 578 highs....
|
|
| 2025-12-15 | HOLD LONG |
|
Summary: ISRG maintains an uptrend with EMA above SMA and both rising, price above both after bouncing from support near 542 without breach, supported by strong fundamentals in robotic surgery demand and no immediate bearish catalysts, justifying continued hold despite the pullback from 578 highs....
|
|
| 2025-12-11 | HOLD LONG |
|
Summary: ISRG remains in an uptrend with EMA above SMA and both rising, price near key support at 546-550 without breach, backed by strong fundamentals in robotic surgery and no immediate bearish catalysts, justifying hold through the pullback....
|
|
| 2025-12-10 | HOLD LONG |
|
Summary: ISRG maintains a solid uptrend with price above rising EMA and SMA, no breach of key support around 546-550, supported by strong fundamentals in robotic surgery and recent positive news on procedure growth, justifying continued hold despite the minor pullback from 580 highs....
|
|
| 2025-12-09 | HOLD LONG |
|
Summary: ISRG remains in a confirmed uptrend with price above rising EMA and SMA, no breakdown below key support near 565, bolstered by strong fundamentals in robotic surgery and positive analyst sentiment, despite a minor pullback, warranting continued hold beyond the initial 8 bars....
|
|
| 2025-12-08 | HOLD LONG |
|
Summary: ISRG continues in a solid uptrend with price above rising EMA and SMA, no breakdowns below key support near 565, supported by strong fundamentals in robotic surgery and positive momentum from recent earnings beats, with no imminent catalysts warranting an exit after only 7 bars....
|
|
| 2025-12-05 | HOLD LONG |
|
Summary: ISRG remains in a confirmed uptrend with EMA above SMA, price above both and rising, holding above key support near 565 without breakdowns, bolstered by positive momentum from recent earnings beats and no imminent catalysts....
|
|
| 2025-12-04 | HOLD LONG |
|
Summary: ISRG maintains a solid uptrend with EMA above SMA, price above both and rising, holding above key support near 565 after a minor pullback from 580 resistance, supported by positive post-earnings momentum and no immediate catalysts or breakdowns....
|
|
| 2025-12-03 | HOLD LONG |
|
Summary: ISRG remains in a confirmed uptrend with EMA above SMA, price above both and both rising, holding above key support near 565 after a minor pullback from 580 resistance, bolstered by positive momentum from recent earnings and no immediate catalysts....
|
|
| 2025-12-01 | HOLD LONG |
|
Summary: ISRG maintains a solid uptrend with EMA above SMA, price above both and both rising, holding above key support near 565 after a shallow pullback from 580 resistance, supported by positive momentum from recent earnings beat and no immediate catalysts or earnings within 3 days....
|
|
| 2025-11-28 | HOLD LONG |
|
Summary: ISRG remains in a strong uptrend with EMA above SMA, price above both and moving upward, holding above key support near 565 after a minor pullback from 580 resistance, bolstered by positive momentum from recent earnings beat and no immediate catalysts....
|
|
| 2025-11-26 | BUY |
|
Summary: ISRG is in a confirmed uptrend with EMA above SMA, price above both and moving upward, presenting a high-confidence dip-buy opportunity after a minor pullback from recent highs near 580 resistance, supported by strong post-earnings momentum and no immediate catalysts....
|
|
| 2025-11-25 | SOLD |
|
Summary: ISRG has reached near the targeted resistance around 585 amid sustained uptrend and positive momentum from recent earnings, prompting profit-taking to lock in gains from the long entry at 546.51 while avoiding potential reversal at key levels....
|
|
| 2025-11-24 | HOLD LONG |
|
Summary: ISRG continues its strong uptrend with price above rising EMA and SMA, recent momentum from positive earnings and breakout holding without breakdowns, targeting 585-616 resistance amid supportive fundamentals and no imminent catalysts....
|
|
| 2025-11-21 | HOLD LONG |
|
Summary: ISRG remains in a solid uptrend with price above rising EMA and SMA, recent breakout momentum from strong earnings holding firm without bearish breakdowns, and no immediate catalysts or resistance breaches signaling an exit yet, targeting potential push toward 585 resistance....
|
|
| 2025-11-20 | HOLD LONG |
|
Summary: ISRG continues in a strong uptrend with price above rising EMA and SMA, recent consolidation above key support near 544-546 showing resilience, positive momentum from post-earnings breakout, and no immediate bearish catalysts or earnings, targeting resistance at 585-616....
|
|
| 2025-11-19 | HOLD LONG |
|
Summary: ISRG remains in a confirmed uptrend with price above rising EMA and SMA, recent bounce from 544 support on high volume signaling strength, no bearish catalysts or imminent earnings, targeting resistance near 585-616....
|
|
| 2025-11-17 | HOLD LONG |
|
Summary: ISRG continues in a strong uptrend with price above rising EMA and SMA, holding above key support near 530-540 after pulling back from 576 high, supported by positive momentum post-earnings and no imminent bearish catalysts....
|
|
| 2025-11-14 | HOLD LONG |
|
Summary: ISRG remains in a confirmed uptrend with price above rising EMA and SMA, recent pullback from 576 high holding above key support near 546 entry and rising trendline at 496, bolstered by strong post-earnings momentum and no bearish catalysts....
|
|
| 2025-11-13 | HOLD LONG |
|
Summary: ISRG maintains a strong uptrend with price above rising EMA and SMA, recent post-earnings breakout holding gains toward 584-616 resistance, supported by positive momentum in robotic surgery sector and no imminent bearish catalysts....
|
|
| 2025-11-12 | HOLD LONG |
|
Summary: ISRG continues its strong uptrend with EMA above SMA, both rising, price above both and holding key supports near 570-572, bolstered by recent earnings momentum and no imminent bearish catalysts, targeting resistance at 584-616 over the coming weeks....
|
|
| 2025-11-11 | HOLD LONG |
|
Summary: ISRG maintains a strong uptrend with EMA above SMA, both rising, price above both, holding above key supports near 540-565 while pushing toward resistance at 585-616, supported by recent earnings beat and no imminent bearish catalysts....
|
|
| 2025-11-10 | HOLD LONG |
|
Summary: ISRG continues its strong uptrend with EMA above SMA, both rising, price well above both after the post-earnings breakout, holding above supports near 530-540 while targeting resistance at 585-616, with no immediate bearish catalysts or events. Technical indicators support continuation: RSI at 76 indicates strength but not extreme overbought, MACD positive and expanding at 27.0254 above signal line, Stochastic K/D at 97/94 showing momentum, and Bollinger Bands expanding with price near upper band. No volume capitulation recently, but the prior downtrend ended with the earnings gap-up, invalidating bearish setups....
|
|
| 2025-11-07 | HOLD LONG |
|
Summary: ISRG remains in a confirmed uptrend with EMA above SMA, both rising, price well above both after a strong post-earnings breakout, holding above key supports around 530-540, with no immediate bearish catalysts or upcoming events to disrupt the momentum toward 580-600 resistance....
|
|
| 2025-11-06 | HOLD LONG |
|
Summary: ISRG continues in a solid uptrend with EMA above SMA, both rising, price holding above key supports post-earnings breakout, supported by positive fundamentals in robotic surgery and no immediate bearish catalysts....
|
|
| 2025-11-05 | HOLD LONG |
|
Summary: ISRG maintains a strong uptrend with EMA above SMA, both rising, price above both, post-earnings momentum holding above key supports like the rising trendline near 475, with no bearish breakdowns or upcoming catalysts signaling an exit....
|
|
| 2025-11-04 | HOLD LONG |
|
Summary: ISRG remains in a confirmed uptrend with EMA above SMA, both rising, price above both after post-earnings breakout, with pullback holding above key supports like 530 and rising trendline near 472, supported by strong robotic surgery demand and no major bearish news....
|
|
| 2025-11-03 | HOLD LONG |
|
Summary: ISRG maintains a confirmed uptrend with EMA above SMA, both rising, price above both after the post-earnings breakout to 552, with the recent pullback to 527 on moderate volume holding above key supports like 530 and the rising trendline near 470, bolstered by strong fundamentals in robotic surgery demand and no bearish catalysts outweighing the positive momentum....
|
|
| 2025-10-31 | HOLD LONG |
|
Summary: ISRG remains in a confirmed uptrend with EMA above SMA, both rising, price above both after a post-earnings breakout, and the recent pullback to 534 on moderate volume hasn't broken key supports like 530 or the prior low at 454, supported by strong fundamentals in robotic surgery demand and no immediate bearish catalysts....
|
|
| 2025-10-30 | HOLD LONG |
|
Summary: ISRG maintains a confirmed uptrend with EMA above SMA, both rising, price above both after post-earnings breakout to 551, current pullback to 531 on lower volume without breaking key supports like 530 or prior capitulation at 454, supported by strong fundamentals in robotic surgery demand and positive earnings history....
|
|
| 2025-10-29 | HOLD LONG |
|
Summary: ISRG remains in a confirmed uptrend with EMA above SMA, both rising and price above them after post-earnings breakout, despite a minor pullback to 537 on low volume without breaking key supports, supported by strong fundamentals in robotic surgery demand and no immediate catalysts....
|
|
| 2025-10-28 | HOLD LONG |
|
Summary: ISRG maintains a strong uptrend with EMA above SMA, price above both and trending upward post-earnings breakout, high-volume surge to 551+, positive robotic surgery demand, no near-term catalysts, targeting resistance at 585-616 despite minor pullback....
|
|
| 2025-10-27 | HOLD LONG |
|
Summary: ISRG remains in a confirmed uptrend post-earnings breakout with EMA above SMA, price above both and moving upward, recent high-volume surge to new highs near 552, positive fundamentals in robotic surgery demand, and no immediate catalysts or breakdowns, targeting resistance around 585-616 over the coming weeks....
|
|
| 2025-10-24 | BUY |
|
Summary: ISRG has broken out strongly on high volume post-earnings with EMA above SMA, price above both and moving upward, confirming an uptrend after a prolonged downtrend, supported by positive earnings reaction and no immediate catalysts, targeting resistance near 585-616 over the next few weeks....
|
|
| 2025-10-23 | CASH |
|
Summary: Recent earnings beat on 10/21/2025 drove a massive gap up to new highs, but overbought indicators like RSI 81 and STO_K 88 signal high risk of a near-term pullback despite the emerging uptrend, making entry unfavorable now with downside potentially outweighing upside to resistance at 584....
|
|
| 2025-10-22 | CASH |
|
Summary: Trend remains unclear with EMA below SMA but price gapping above both on high-volume earnings reaction, avoiding new entries amid overbought RSI/STO_K levels signaling potential pullback despite positive fundamentals....
|
|
| 2025-10-21 | CASH |
|
Summary: ISRG remains in an unclear trend with EMA below SMA and no valid volume capitulation for a long entry, while shorting is prohibited due to its biotech nature and lack of confirmed downtrend, compounded by recent post-earnings bounce but overbought indicators signaling caution....
|
|
| 2025-10-20 | CASH |
|
Summary: Staying in cash due to unclear trend with EMA below SMA despite price above both, no recent volume capitulation for long entry in downtrend, prohibition on shorting biotech stocks like ISRG especially with capitulation within two months, and earnings tomorrow preventing new positions....
|
|
| 2025-10-17 | CASH |
|
Summary: ISRG remains in a clear downtrend with EMA below SMA and price below both, no recent volume capitulation for a long entry, inability to short due to prior capitulation within two months and its biotech status, plus upcoming earnings on 10/21/2025 warrant staying in cash to avoid risk....
|
|
| 2025-10-16 | CASH |
|
Summary: Staying in cash due to clear downtrend without recent volume capitulation, inability to short given capitulation on 9/4 within past 2 months, no high-confidence setup for long, and earnings today which meet hold-through criteria but we're not positioned and avoid entry on earnings day....
|
|
| 2025-10-15 | CASH |
|
Summary: Staying in cash due to clear downtrend without new volume capitulation for long entry, recent capitulation barring short entry, and earnings tomorrow preventing new positions, with technicals showing weak support at 429.6 amid bearish momentum....
|
|
| 2025-10-14 | CASH |
|
Summary: ISRG remains in a clear downtrend with EMA below SMA and price below both, no recent volume capitulation for a long entry, while shorting is avoided due to the stock's biotech nature, recent capitulation within two months, and upcoming earnings on 10/16/2025 introducing volatility risk....
|
|
| 2025-10-13 | CASH |
|
Summary: ISRG remains in a clear downtrend with EMA below SMA and price below both, lacking recent volume capitulation for a long entry while recent capitulation within two months and biotech status preclude shorting, compounded by upcoming earnings on 10/16/2025 introducing volatility risk....
|
|
| 2025-10-10 | CASH |
|
Summary: ISRG remains in a clear downtrend with price below both EMA and SMA, no recent volume capitulation to justify a long entry, and as a medtech stock it's unsuitable for shorting due to high risk of sudden positive news spikes, while upcoming earnings on 10/16/2025 prevent new positions given the minimum hold period and lack of qualifying positive historical reactions....
|
|
| 2025-10-09 | CASH |
|
Summary: ISRG remains in a clear downtrend with EMA below SMA and price below both, lacking recent volume capitulation for a long entry while the recent capitulation within two months precludes a short, and no high-confidence setup justifies a position ahead of earnings in seven days....
|
|
| 2025-10-08 | CASH |
|
Summary: Staying in cash as ISRG remains in a clear downtrend with EMA below SMA and price below both, no volume capitulation for a long entry, and shorting biotech stocks like this is avoided due to high risk of sudden positive news spikes. Technical indicators like RSI at 48.6 suggest neutral momentum, not oversold, and STO_K at 61.6 indicates no immediate reversal signal....
|
|
| 2025-10-07 | CASH |
|
Summary: Persistent downtrend with EMA below SMA and price below both, recent volume capitulation on 9/4 invalidates short entry while no new capitulation supports long, and upcoming earnings on 10/16/2025 prevent new positions to avoid holding through without meeting surprise criteria....
|
|
| 2025-10-06 | CASH |
|
Summary: ISRG remains in a confirmed downtrend with EMA below SMA and price below both, lacking recent volume capitulation for a long entry, while upcoming earnings on 10/16/2025 conflict with the minimum hold period without meeting hold-through criteria, and shorting is prohibited for this biotech stock....
|
|
| 2025-10-03 | CASH |
|
Summary: Downtrend confirmed with EMA below SMA and price below both, recent capitulation on 9/4 prevents short entry, no new capitulation for long despite oversold signals, and upcoming earnings on 10/16 would require holding through if entering now for multi-week horizon....
|
|
| 2025-10-02 | CASH |
|
Summary: Downtrend persists with price below EMA and SMA, no new volume capitulation for long entry, recent capitulation within 2 months and biotech nature prevent short, upcoming earnings on 10/16/2025 without criteria to hold through, and past failed longs in similar setups suggest waiting for better opportunity....
|
|
| 2025-10-01 | CASH |
|
Summary: ISRG remains in a clear downtrend with EMA below SMA and price below both, lacking a valid volume capitulation for long entry and blocked from short due to recent capitulation within 2 months, while upcoming earnings on 10/16/2025 add risk without meeting hold-through criteria....
|
|
| 2025-09-30 | CASH |
|
Summary: The stock remains in a downtrend without new volume capitulation for long entry, shorting is precluded by biotech status and recent capitulation, and no compelling catalysts override the bearish technicals for a high-confidence multi-week trade....
|
|
| 2025-09-29 | CASH |
|
Summary: Staying in cash as ISRG remains in a clear downtrend with EMA below SMA and price below both, no new volume capitulation for long entry, and recent capitulation within 2 months prevents short entry, while past similar setups led to losses on premature longs....
|
|
| 2025-09-26 | CASH |
|
Summary: In a confirmed downtrend without new volume capitulation to justify a long entry and with a recent capitulation barring a short, staying in cash avoids low-confidence trades while awaiting clearer opportunities....
|
|
| 2025-09-25 | CASH |
|
Summary: ISRG remains in a clear downtrend with EMA below SMA and price below both, lacking new volume capitulation for a long entry, while recent capitulations led to invalidated bounces and losses, and shorting is avoided due to the stock's biotech nature and prior capitulation within two months....
|
|
| 2025-09-24 | CASH |
|
Summary: ISRG remains in a clear downtrend with price below both EMA and SMA, no new volume capitulation for a long entry, and shorting is avoided due to recent capitulation within 2 months plus its biotech nature prone to positive catalysts. Technical indicators like RSI at 42.48 indicate neither extreme oversold nor overbought, while MACD (-9.83) confirms bearish momentum, and the stock is trading below key resistance at 475.6 but above support around 430. The volume capitulation on 9/4/2025 at 454.52 was already used and invalidated by subsequent breakdowns, so it can't justify a new long here without a fresh signal....
|
|
| 2025-09-23 | CASH |
|
Summary: ISRG remains in a clear downtrend with EMA below SMA and price below both, recent long trades resulted in losses due to breakdowns below capitulation lows, no high-confidence setup for long given history of false bounces and no new bullish catalysts, while shorting is avoided due to recent volume capitulation and biotech sector risks....
|
|
| 2025-09-22 | CASH |
|
Summary: Persistent downtrend with price below EMA and SMA, no new volume capitulation to justify long entry, and recent similar setups resulted in losses, while short entry is barred due to capitulation within past 2 months....
|
|
| 2025-09-19 | CASH |
|
Summary: Staying in cash as ISRG remains in a clear downtrend with EMA below SMA and price below both, no new volume capitulation for a long entry, recent capitulation invalidated by sustained lower prices, and shorting biotech stocks like ISRG is avoided due to high risk of sudden positive news....
|
|
| 2025-09-18 | CASH |
|
Summary: ISRG remains in a clear downtrend with price below both EMA and SMA, no new volume capitulation for a long entry, and shorting is avoided due to its biotech nature prone to sudden positive news, while recent trade history shows repeated losses on similar long attempts....
|
|
| 2025-09-17 | CASH |
|
Summary: Downtrend persists with EMA below SMA and price below both, recent volume capitulation on 9/4 prevents short entry, and price breaking below that capitulation low of 437.41 invalidates long entry opportunities, so remain in cash for a higher-confidence setup....
|
|
| 2025-09-16 | CASH |
|
Summary: The stock remains in a clear downtrend with EMA below SMA and price below both, recent volume capitulation on 9/4 failed as price broke below the low without sustaining 5 bars yet but led to exit on 9/15, no new capitulation or reversal signals today despite testing support at 429.6, and as a biotech stock we avoid shorting, so cash is best to sidestep further downside risk....
|
|
| 2025-09-15 | SOLD |
|
Summary: Exit the long position as ISRG has broken below the 9/4/2025 capitulation low of $437.41 on high volume without reversal signals, mirroring the prior loss on 9/3/2025 and invalidating the bounce thesis amid persistent downtrend....
|
|
| 2025-09-12 | HOLD LONG |
|
Summary: ISRG continues to hold above the 9/4/2025 capitulation low of $437.41 without a sustained 5-bar breakdown, supporting ongoing long position amid downtrend while monitoring support at $429.60....
|
|
| 2025-09-11 | HOLD LONG |
|
Summary: ISRG's price remains above the 9/4/2025 capitulation low of around $437 without a sustained 5-bar breakdown, supporting continued holding in this bounce phase while monitoring nearby support at $429.60 amid the ongoing downtrend....
|
|
| 2025-09-10 | HOLD LONG |
|
Summary: ISRG remains above the 9/4/2025 volume capitulation low of $437 with no sustained breakdown below it for 5+ bars, and the position is only 4 bars old, warranting continued holding despite the downtrend to meet minimum hold periods while monitoring for support at $429.60. Momentum indicators like STO_K at 44.15 have dipped but remain above oversold levels, and RSI at 37.14 suggests potential for stabilization without immediate capitulation signals. Visual indicators confirm a lower conviction "!" capitulation 4 bars ago, and support at $429.60 (strength 3, recently tested) could provide a floor, while resistance trendlines around $480-520 suggest overhead pressure but no immediate breakdown....
|
|
| 2025-09-09 | HOLD LONG |
|
Summary: ISRG continues to hold above the 9/4/2025 volume capitulation low around $437 with improving momentum signals like rising STO_K from oversold levels, no immediate breakdown below key supports, and no near-term earnings or catalysts identified. RSI at 45.61 is neutral, STO_K at 55.13 shows short-term strength, and volume has tapered post-spike, suggesting potential stabilization....
|
|
| 2025-09-08 | HOLD LONG |
|
Summary: ISRG's price has bounced from the 9/4 volume capitulation low of around $437 without sustaining below it, maintaining above key supports while RSI and STO_K show improving momentum in a potential reversal setup, with no near-term earnings or catalysts to disrupt the hold....
|
|
| 2025-09-05 | HOLD LONG |
|
Summary: ISRG's recent volume capitulation on 9/4 at $454.52 supports holding the long position amid a bounce to $466.19 close, with RSI improving to 44 and STO_K at 35 indicating potential reversal in the downtrend, no immediate earnings risk....
|
|
| 2025-09-04 | BUY |
|
Summary: ISRG shows a strong bounce from oversold lows with volume capitulation flagged today at 453.42, in a downtrend but with RSI at 36 and STO_K at 21 indicating reversal potential, justifying re-entry soon after 9/3 exit due to new lower low capitulation and intraday recovery from 437.45....
|
|
| 2025-09-03 | SOLD |
|
Summary: Exit the long position as price has broken sharply below the 8/7/2025 BOT capitulation low of $463.9 on high volume without immediate reversal signals, confirming downtrend continuation with EMA below SMA and price below both, while no major bullish catalysts offset the bearish technical breakdown....
|
|
| 2025-09-02 | HOLD LONG |
|
Summary: Hold the existing long position as the 8/7/2025 BOT capitulation at $463.9 remains valid without a 5-bar breach below it, price is testing strong support around $463-$468 without breaking, and the downtrend shows signs of exhaustion near this level with no immediate catalysts for exit....
|
|
| 2025-08-29 | HOLD LONG |
|
Summary: Hold the existing long as the 8/7/2025 BOT capitulation at $463.9 remains valid without a 5-bar breach below it, price holds above key $463-$468 support in the downtrend, and no earnings or catalysts within 3 days justify exit....
|
|
| 2025-08-28 | HOLD LONG |
|
Summary: Hold the existing long position as the BOT capitulation at $463.9 on 8/7/2025 remains valid without a 5-bar sustained breach below it, price is stabilizing above key support near $463-$468 amid the ongoing downtrend, and no immediate earnings or catalysts warrant an exit. This aligns with the entry rationale from 7/24/2025, which was also based on capitulation after a post-earnings drop, and we've already held past the minimum 10-14 days (now ~35 days from entry). Technical indicators support caution but not an exit: RSI at 40.99 is neutral, not oversold to force selling; STO_K at 29.17 suggests potential for bounce; MACD at -7.65 is bearish but improving from deeper negatives. Support levels at $463.05 (strength 2, recent bounces) and a rising trendline at ~$458 reinforce the floor, while resistance trendlines around $492-$525 could cap upside, but we're not near them yet—erring against selling near bottoms....
|
|
| 2025-08-27 | HOLD LONG |
|
Summary: Hold the existing long position as the BOT capitulation at $463.9 remains valid without a 5-bar sustained breach below, price is holding above key support at $463 amid a downtrend, with no immediate earnings or catalysts to force an exit....
|
|
| 2025-08-26 | HOLD LONG |
|
Summary: Continue holding the long position as the valid BOT capitulation at $463.9 on 8/7/2025 supports reversal potential in the downtrend, with price above the low and near key support at $463 without a 5-bar breach, despite EMA below SMA and price below both....
|
|
| 2025-08-25 | HOLD LONG |
|
Summary: Continue holding the long position as the BOT capitulation at $463.9 on 8/7/2025 remains valid without a sustained 5-bar breach below it or bounce to SMA, maintaining reversal potential in the ongoing downtrend near key support levels despite recent volatility....
|
|
| 2025-08-22 | HOLD LONG |
|
Summary: Continue holding the long position as the BOT capitulation at $463.9 on 8/7/2025 remains valid with no sustained breach below for 5 consecutive bars and no bounce to SMA yet, suggesting ongoing potential for a reversal bounce in the downtrend despite recent dips....
|
|
| 2025-08-21 | HOLD LONG |
|
Summary: Hold the existing long position as the BOT capitulation at $463.9 on 8/7/2025 remains valid with price closing above that low, no sustained breach below for 5 consecutive bars, and no bounce to SMA yet, suggesting potential for a reversal bounce in the downtrend....
|
|
| 2025-08-20 | HOLD LONG |
|
Summary: Hold the existing long position as the BOT capitulation at $463.9 on 8/7/2025 remains valid with price above that low, no sustained breach below for 5 bars, and no bounce to SMA yet, indicating potential for a reversal bounce in the ongoing downtrend....
|
|
| 2025-08-19 | HOLD LONG |
|
Summary: Hold the existing long as the BOT capitulation at $463.9 on 8/7/2025 remains valid with price still above that low without sustained breach below for 5 bars or bounce to SMA, supporting a potential reversal bounce despite the downtrend....
|
|
| 2025-08-18 | HOLD LONG |
|
Summary: Hold the existing long position as the BOT capitulation at $463.9 on 8/7/2025 remains valid with price above that low, no sustained breach below for 5 bars, and no bounce to SMA yet, despite the ongoing downtrend....
|
|
| 2025-08-15 | HOLD LONG |
|
Summary: Hold the existing long as the BOT capitulation at $463.9 on 8/7/2025 remains valid with price still above that low without sustaining below for 5 bars and no bounce to SMA yet, despite ongoing downtrend, supported by ISRG's strong position in robotic surgery amid no near-term catalysts....
|
|
| 2025-08-14 | HOLD LONG |
|
Summary: Hold the existing long position as the BOT capitulation at $463.9 on 8/7/2025 remains valid with price above the low without sustaining below for 5 bars or bouncing to SMA, in a downtrend but supported by ISRG's leadership in robotic surgery and no immediate catalysts....
|
|
| 2025-08-13 | HOLD LONG |
|
Summary: Hold the existing long as the BOT capitulation at $463.9 on 8/7/2025 remains valid with price staying above without sustaining below for 5 bars or reaching SMA, despite downtrend, supported by ISRG's strong robotic surgery fundamentals and no near-term catalysts....
|
|
| 2025-08-12 | HOLD LONG |
|
Summary: Hold the existing long position as the recent BOT volume capitulation on 8/7/2025 at $463.9 remains valid with price holding above without sustaining below for 5 bars, in a downtrend but with potential reversal supported by strong fundamentals in robotic surgery and no immediate catalysts....
|
|
| 2025-08-11 | HOLD LONG |
|
Summary: Hold the existing long position as the BOT volume capitulation on 8/7/2025 at $463.9 signals a potential reversal bottom, with price holding above without sustaining below for 5 bars, supported by strong fundamentals in robotic surgery and no immediate earnings catalysts. Price has bounced slightly to 471.61 without breaking below the capitulation low for 5 consecutive bars, maintaining validity of the signal; previous similar BOT events in the data, like on 8/1 at $483.12, led to short-term stabilizations or bounces, though volatility persisted....
|
|
| 2025-08-08 | HOLD LONG |
|
Summary: Hold the long position as the recent BOT volume capitulation on 8/7 at $463.9 indicates a potential reversal bottom in the downtrend, supported by strong Q2 2025 earnings beating estimates with 17% procedure growth, positive analyst updates like Leerink's $593 PT and buy rating, and bullish sentiment on X seeing ISRG as a robotics leader with $1T potential, while price on 8/8 closed at 471.28 above the low without sustaining below for 5 bars, invalidating prior capitulations but signaling a fresh bounce opportunity toward 520-550 resistance. This echoes past setups like the March 2025 capitulation around 476 that led to a multi-week rally to 520+, or the April low at 425 bouncing sharply to 523 within days; simulating forward, if it follows those, we could see a volatile rebound with pullbacks above 463.9 offering adds, but invalidation only on sustained breaks lower. Avoided exiting near this bottom to prevent repeating the July 21 small-loss mistake of cutting in a downtrend without capitulation confirmation, focusing instead on the bigger monthly move potential....
|
|
| 2025-08-07 | HOLD LONG |
|
Summary: Continue holding the long position as the new "BOT" volume capitulation today at $463.9 signals a potential reversal bottom despite the ongoing downtrend, with previous capitulations at $481.09 and $473.24 still valid since price hasn't sustained below those lows for 5 consecutive bars, bolstered by ISRG's strong Q2 2025 earnings with 17% procedure growth and positive analyst updates targeting $520-550 resistance....
|
|
| 2025-08-06 | HOLD LONG |
|
Summary: Continue holding the long position as the "BOT" volume capitulations at $481.09 (7/31/2025) and $473.24 (8/1/2025) remain valid with price above those lows, despite the current downtrend, supported by ISRG's robust Q2 2025 earnings beating estimates with 17% procedure growth and positive analyst updates aiming for $520-550 resistance over the next few weeks....
|
|
| 2025-08-05 | HOLD LONG |
|
Summary: Continue holding the long position as the recent "BOT" volume capitulations on 7/31/2025 at $481.09 and 8/1/2025 at $473.24 remain valid with price staying above those lows, reinforced by ISRG's strong Q2 2025 earnings with 17% procedure growth, analyst price targets up to $599, and robust demand for robotic surgery, aiming for a multi-week rebound toward $520-550 resistance....
|
|
| 2025-08-04 | HOLD LONG |
|
Summary: Hold the existing long position as recent high-conviction "BOT" volume capitulations on 8/1/2025 at $473.24 and 7/31/2025 at $481.09 signal a potential reversal bottom in the downtrend, with price holding above the lows and reinforced by ISRG's robust Q2 2025 earnings showing 17% procedure volume growth, positive analyst upgrades, and strong demand for robotic surgery systems, targeting a rebound toward $520-550 resistance over the next few weeks....
|
|
| 2025-08-01 | HOLD LONG |
|
Summary: Hold the existing long position as today's volume capitulation "BOT" at $473.44 signals a high-conviction reversal bottom amid an oversold downtrend, reinforced by ISRG's strong Q2 2025 earnings with 17% procedure growth, 395 da Vinci installations, and positive analyst sentiment on robotic surgery demand, targeting a multi-week rebound toward $520-550 resistance....
|
|
| 2025-07-31 | HOLD LONG |
|
Summary: ISRG's chart shows a high-conviction volume capitulation "BOT" today at $483.13, signaling a potential reversal bottom after a downtrend pullback, supported by strong Q2 2025 earnings beats, 17% procedure volume growth, positive analyst updates, and ongoing robotic surgery demand, holding the existing long for a multi-week rebound toward 520-550 resistance....
|
|
| 2025-07-30 | HOLD LONG |
|
Summary: ISRG remains in a post-capitulation rebound with price holding above recent lows around 486-493, supported by strong Q2 2025 earnings beats, raised guidance, positive analyst price target hikes to 600, and ongoing procedure volume growth, targeting a multi-week push toward 520-550 resistance despite the broader downtrend....
|
|
| 2025-07-29 | HOLD LONG |
|
Summary: ISRG is rebounding from recent volume capitulation lows around 486-493 with strong Q2 earnings beats and positive analyst updates supporting a multi-week recovery toward 520-550 resistance, despite the ongoing downtrend....
|
|
| 2025-07-28 | HOLD LONG |
|
Summary: ISRG's recent volume capitulation signals a potential bottom after strong Q2 earnings beat and analyst price target increases, supporting holding the long position for a multi-week recovery toward 520-550 resistance despite the ongoing downtrend....
|
|
| 2025-07-25 | HOLD LONG |
|
Summary: ISRG's price bounced slightly to 493.72 after volume capitulation at 488.61 entry amid strong Q2 earnings beats and raised guidance, supporting holding the long for a potential multi-week reversal despite ongoing downtrend....
|
|
| 2025-07-24 | BUY |
|
Summary: ISRG shows volume capitulation on 7/24/2025 at oversold levels after a post-earnings drop, combined with strong Q2 results beating estimates and raised guidance, signaling a potential reversal for a multi-week bounce toward 520-550 resistance despite the current downtrend....
|
|
| 2025-07-23 | CASH |
|
Summary: ISRG is in a clear downtrend with price below both EMA and SMA after a post-earnings sell-off on weak guidance despite strong Q2 results, showing oversold indicators but no volume capitulation flag for a long entry, while shorting near key support at 501 risks a bounce given high volume and positive analyst updates like Wells Fargo's $599 price target....
|
|
| 2025-07-22 | CASH |
|
Summary: ISRG remains in a confirmed downtrend with price below both EMA and SMA, but recent exit from long position at a higher price advises patience to avoid shorting lower immediately after a loss, while no high-confidence reversal signals or catalysts support a new entry....
|
|
| 2025-07-21 | SOLD |
|
Summary: ISRG has entered a clear downtrend with EMA below SMA and price below both, invalidating the long-term uptrend assumption from entry, while lacking volume capitulation to signal a reversal, prompting an exit to preserve capital despite the minimum hold period....
|
|
| 2025-07-18 | HOLD LONG |
|
Summary: Continuing LONG on ISRG as the stock shows early signs of recovery from oversold levels, holding above 515 support with improving indicators and positive fundamentals supporting a bounce toward 550+ resistance....
|
|
| 2025-07-17 | BUY |
|
Summary: ISRG shows oversold conditions with STO_K at 13.15 and RSI 42, stabilizing near 515 support after a pullback, while strong fundamentals in robotic surgery and recent positive news on da Vinci system expansions support a multi-week bounce toward 550+ resistance....
|
|